Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Malaria Vaccines Global Market Report 2025
Request Sample Buy Now
Global Malaria Vaccines Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Malaria Vaccines Global Market Report 2025

By Agent (Plasmodium Falciparum, Plasmodium Vivax, Anopheles Species), By Vaccine Type (Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines), By Route of Administration (Intramuscular, Subcutaneous, Intradermal, Other Routes), By Distribution Channel (Public, Private) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Malaria Vaccines Market Overview

• Malaria Vaccines market size has reached to $4.7 billion in 2024

• Expected to grow to $20.19 billion in 2029 at a compound annual growth rate (CAGR) of 34.1%

• Growth Driver: Malaria Vaccine Market Poised For Growth Amidst Rising Mosquito-Related Diseases

• Market Trend: Innovations And Strategies To Combat Mosquito-Borne Diseases

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Malaria Vaccines Market?

Malaria vaccines are specific vaccines designed to prevent malaria, a potentially deadly mosquito-borne infectious disease caused by parasites from the Plasmodium genus. These vaccines aim to provide immunity against the plasmodium parasites that cause malaria.

The main types of agents involved in malaria vaccines are plasmodium falciparum, plasmodium vivax, and anopheles species. Plasmodium falciparum is a protozoan parasite responsible for the most severe and deadly form of malaria in humans. The various types of vaccines include pre-erythrocytic, erythrocytic, multi-antigen, and others, which can be administered through various routes, such as intramuscular, subcutaneous, intradermal, and others. These are sold through several distribution channels, including public and Private.

Malaria Vaccines Market Size and growth rate 2025 to 2029: Graph

What Is The Malaria Vaccines Market Size 2025 And Growth Rate?

The malaria vaccines market size has grown exponentially in recent years. It will grow from $4.7 billion in 2024 to $6.24 billion in 2025 at a compound annual growth rate (CAGR) of 32.7%. The growth in the historic period can be attributed to high malaria burden, global health initiatives, funding and grants, malaria control programs, government support and regulatory frameworks.

What Is The Malaria Vaccines Market Growth Forecast?

The malaria vaccines market size is expected to see exponential growth in the next few years. It will grow to $20.19 billion in 2029 at a compound annual growth rate (CAGR) of 34.1%. The growth in the forecast period can be attributed to global elimination goals, expanded access programs, increasing vaccine coverage, global vaccine alliances, climate change impact. Major trends in the forecast period include technological innovations, public-private partnerships, international collaboration, advancements in vaccine technology, advancements in vaccine technology.

The forecast of 34.1% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. global health initiatives by increasing costs for RTS,S/AS01 (Mosquirix) vaccines and adjuvant systems imported from the UK and Spain, potentially undermining outbreak preparedness and raising public health program expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Malaria Vaccines Market Segmented?

1) By Agent: Plasmodium Falciparum, Plasmodium Vivax, Anopheles Species

2) By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines

3) By Route Of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes

4) By Distribution Channel: Public, Private

Subsegments:

1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine, Other Experimental Vaccines

2) By Plasmodium Vivax: Candidate Vaccines In Development, Combination Vaccines

3) By Anopheles Species: Transmission-Blocking Vaccines, Vector Control Approaches

What Is Driving The Malaria Vaccines Market? Malaria Vaccine Market Poised For Growth Amidst Rising Mosquito-Related Diseases

A rise in the incidence of mosquito-related diseases is expected to propel the growth of the malaria vaccine market going forward. Mosquito-related diseases are a broad category of illnesses spread by the bite of an infected mosquito. The malaria vaccine, particularly the RTS, S/AS01 (RTS, S) vaccine, is used to prevent and reduce the impact of mosquito-borne infectious diseases by training the immune system to recognize and attack the parasite. For instance, in November 2023, according to a report published by the World Health Organization, a Switzerland-based intergovernmental organization, estimated 249 million cases of malaria occurred globally in 2022, with an increase of 5 million cases from 2021. Further, Pakistan reported an estimated 2.6 million cases in 2022, a notable increase from the 500,000 cases reported in 2021. Therefore, the rise in the incidence of mosquito-related diseases is driving the growth of the malaria vaccine industry.

Who Are The Major Players In The Global Malaria Vaccines Market?

Major companies operating in the malaria vaccines market report are Pfizer Inc., Ipca Laboratories Ltd., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., Takeda Pharmaceutical Co Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Lupin, Taj Pharmaceuticals Limited., Nobelpharma Co. Ltd., Bliss GVS Pharma Ltd., Sanaria Inc., Precigen Inc., AdvaCare Pharma, CellFree Sciences, Actiza Pharmaceutical Private Limited, Sumaya Biotech, VLP Therapeutics LLC, GeoVax Labs Inc., Zydus Cadila, Genvec Inc.

What Are The Key Trends Of The Global Malaria Vaccines Market? Innovations And Strategies To Combat Mosquito-Borne Diseases

Major companies operating in the malaria vaccine market are developing innovative products, such as vaccines for children's malaria, to meet larger customer bases, increase sales, and increase revenue. Vaccines for mosquito-borne diseases are immunological formulations designed to protect against illnesses transmitted by mosquitoes. It is a pediatric vaccine against Plasmodium falciparum, the deadliest malaria parasite globally and the most prevalent in Africa. For instance, in November 2022, Malawi, a country in East Africa, and the World Health Organization, a Switzerland-based intergovernmental organization, launched Africa's first children's malaria vaccine. The distinctive characteristic of the RTSS vaccine, designed for young children, is its potential to decrease mortality from the mosquito-borne disease. Having undergone pilot testing on over one million children in Ghana, Kenya, and Malawi, the vaccine, despite a modest effectiveness rate of 30%, has instilled optimism that IT could save lives among the 400,000 individuals who succumb to malaria each year.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Malaria Vaccines Market? GlaxoSmithKline Strengthens Vaccine Portfolio With Acquisition Of Affinivax Inc.

In August 2022, GlaxoSmithKline PLC, a UK-based biopharmaceutical company, acquired Affinivax Inc. for $3.3 billion. This acquisition of Affinivax Inc., with its innovative vaccine technology, might enable GSK to enhance its pipeline of novel vaccines and presence in the Boston area. Affinivax Inc. is a US-based provider of vaccine technology for developing malaria vaccines.

What Is The Regional Outlook For The Global Malaria Vaccines Market?

North America was the largest region in the malaria vaccines market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Malaria Vaccines Market?

The malaria vaccines market consists of sales of circumsporozoite protein (CSP) antigens, multi-component adjuvants, and circumsporozoite protein. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Malaria Vaccines Industry?

The malaria vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the malaria vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Malaria Vaccines Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $6.24 billion
Revenue Forecast In 2034 $20.19 billion
Growth Rate CAGR of 34.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Agent: Plasmodium Falciparum, Plasmodium Vivax, Anopheles Species
2) By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines
3) By Route Of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes
4) By Distribution Channel: Public, Private Subsegments: 1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine, Other Experimental Vaccines
2) By Plasmodium Vivax: Candidate Vaccines In Development, Combination Vaccines
3) By Anopheles Species: Transmission-Blocking Vaccines, Vector Control Approaches
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Ipca Laboratories Ltd., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., Takeda Pharmaceutical Co Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Lupin, Taj Pharmaceuticals Limited., Nobelpharma Co. Ltd., Bliss GVS Pharma Ltd., Sanaria Inc., Precigen Inc., AdvaCare Pharma, CellFree Sciences, Actiza Pharmaceutical Private Limited, Sumaya Biotech, VLP Therapeutics LLC, GeoVax Labs Inc., Zydus Cadila, Genvec Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Malaria Vaccines Market Characteristics

3. Malaria Vaccines Market Trends And Strategies

4. Malaria Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Malaria Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Malaria Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Malaria Vaccines Market Growth Rate Analysis

5.4. Global Malaria Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Malaria Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Malaria Vaccines Total Addressable Market (TAM)

6. Malaria Vaccines Market Segmentation

6.1. Global Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Plasmodium Falciparum

Plasmodium Vivax

Anopheles Species

6.2. Global Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pre-Erythrocytic

Erythrocytic

Multi-antigen

Other Vaccines

6.3. Global Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intramuscular

Subcutaneous

Intradermal

Other Routes

6.4. Global Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Public

Private

6.5. Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Falciparum, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

RTS,S/AS01 Vaccine

Other Experimental Vaccines

6.6. Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Vivax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Candidate Vaccines In Development

Combination Vaccines

6.7. Global Malaria Vaccines Market, Sub-Segmentation Of Anopheles Species, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Transmission-Blocking Vaccines

Vector Control Approaches

7. Malaria Vaccines Market Regional And Country Analysis

7.1. Global Malaria Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Malaria Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Malaria Vaccines Market

8.1. Asia-Pacific Malaria Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Malaria Vaccines Market

9.1. China Malaria Vaccines Market Overview

9.2. China Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Malaria Vaccines Market

10.1. India Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Malaria Vaccines Market

11.1. Japan Malaria Vaccines Market Overview

11.2. Japan Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Malaria Vaccines Market

12.1. Australia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Malaria Vaccines Market

13.1. Indonesia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Malaria Vaccines Market

14.1. South Korea Malaria Vaccines Market Overview

14.2. South Korea Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Malaria Vaccines Market

15.1. Western Europe Malaria Vaccines Market Overview

15.2. Western Europe Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Malaria Vaccines Market

16.1. UK Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Malaria Vaccines Market

17.1. Germany Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Malaria Vaccines Market

18.1. France Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Malaria Vaccines Market

19.1. Italy Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Malaria Vaccines Market

20.1. Spain Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Malaria Vaccines Market

21.1. Eastern Europe Malaria Vaccines Market Overview

21.2. Eastern Europe Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Malaria Vaccines Market

22.1. Russia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Malaria Vaccines Market

23.1. North America Malaria Vaccines Market Overview

23.2. North America Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Malaria Vaccines Market

24.1. USA Malaria Vaccines Market Overview

24.2. USA Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Malaria Vaccines Market

25.1. Canada Malaria Vaccines Market Overview

25.2. Canada Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Malaria Vaccines Market

26.1. South America Malaria Vaccines Market Overview

26.2. South America Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Malaria Vaccines Market

27.1. Brazil Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Malaria Vaccines Market

28.1. Middle East Malaria Vaccines Market Overview

28.2. Middle East Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Malaria Vaccines Market

29.1. Africa Malaria Vaccines Market Overview

29.2. Africa Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Malaria Vaccines Market Competitive Landscape And Company Profiles

30.1. Malaria Vaccines Market Competitive Landscape

30.2. Malaria Vaccines Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Ipca Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GlaxoSmithKline Plc. Overview, Products and Services, Strategy and Financial Analysis

31. Malaria Vaccines Market Other Major And Innovative Companies

31.1. Takeda Pharmaceutical Co Ltd.

31.2. Hikma Pharmaceuticals PLC

31.3. Amneal Pharmaceuticals LLC.

31.4. Lupin

31.5. Taj Pharmaceuticals Limited.

31.6. Nobelpharma Co. Ltd.

31.7. Bliss GVS Pharma Ltd.

31.8. Sanaria Inc.

31.9. Precigen Inc.

31.10. AdvaCare Pharma

31.11. CellFree Sciences

31.12. Actiza Pharmaceutical Private Limited

31.13. Sumaya Biotech

31.14. VLP Therapeutics LLC

31.15. GeoVax Labs Inc.

32. Global Malaria Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Malaria Vaccines Market

34. Recent Developments In The Malaria Vaccines Market

35. Malaria Vaccines Market High Potential Countries, Segments and Strategies

35.1 Malaria Vaccines Market In 2029 - Countries Offering Most New Opportunities

35.2 Malaria Vaccines Market In 2029 - Segments Offering Most New Opportunities

35.3 Malaria Vaccines Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Falciparum, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Vivax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Malaria Vaccines Market, Sub-Segmentation Of Anopheles Species, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Malaria Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Malaria Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Ipca Laboratories Ltd. Financial Performance
  • Table 80: Novartis AG Financial Performance
  • Table 81: Sanofi SA Financial Performance
  • Table 82: GlaxoSmithKline Plc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Falciparum, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Vivax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Malaria Vaccines Market, Sub-Segmentation Of Anopheles Species, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Malaria Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Malaria Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Ipca Laboratories Ltd. Financial Performance
  • Figure 80: Novartis AG Financial Performance
  • Figure 81: Sanofi SA Financial Performance
  • Figure 82: GlaxoSmithKline Plc. Financial Performance

$5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Read More About $5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Read More About Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Read More About Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

View Report

UV Disinfection Equipment Global Market Report 2025 – By Component( UV Lamp, Controller Unit, Quartz Sleeve, Reactor Chamber, Other Components ), By Power Rating( Low, Medium, High ), By Application( Water Treatment, Was...

View Report

Audience Intelligence Platform Global Market Report 2025 – By Type of Platform (Content Intelligence Platforms, Social Media Intelligence Platforms), By Deployment Type (On-Premise, Cloud), By Application (Government, Re...

View Report

Herbal Medicine Global Market Report 2025 – By Product (Capsules And Tablets, Powders, Extracts, Syrups, Other Products), By Category (Herbal Pharmaceuticals, Herbal Functional Foods, Herbal Dietary Supplements, Herbal B...

View Report

Pediatric Vaccine Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, C...

View Report

Erdheim Chester Disease Global Market Report 2025 – By Treatment (Chemotherapy, Immunotherapy, Radiation Therapy, Other Treatments), By Route of Administration (oral, Parenteral, Other Route Of Administration), By Distri...

View Report

Automatic Effluent Samplers Global Market Report 2025 – By Product Type (Portable Samplers, Stationary Samplers), By Distribution Channel ( Direct Sales, Distributors, Online Sales), By Application (Industrial Wastewater...

View Report

Frequently Asked Questions

Malaria vaccines are specific vaccines designed to prevent malaria, a potentially deadly mosquito-borne infectious disease caused by parasites from the Plasmodium genus. These vaccines aim to provide immunity against the plasmodium parasites that cause malaria. For further insights on this market, request a sample here

The market major growth driver - Malaria Vaccine Market Poised For Growth Amidst Rising Mosquito-Related Diseases. For further insights on this market, request a sample here

The malaria vaccines market size has grown exponentially in recent years. It will grow from $4.7 billion in 2024 to $6.24 billion in 2025 at a compound annual growth rate (CAGR) of 32.7%. The growth in the historic period can be attributed to high malaria burden, global health initiatives, funding and grants, malaria control programs, government support and regulatory frameworks. The malaria vaccines market size is expected to see exponential growth in the next few years. It will grow to " $20.19 billion in 2029 at a compound annual growth rate (CAGR) of 34.1%. The growth in the forecast period can be attributed to global elimination goals, expanded access programs, increasing vaccine coverage, global vaccine alliances, climate change impact. Major trends in the forecast period include technological innovations, public-private partnerships, international collaboration, advancements in vaccine technology, advancements in vaccine technology. For further insights on this market, request a sample here

The malaria vaccinesmarket covered in this report is segmented –
1) By Agent: Plasmodium Falciparum; Plasmodium Vivax; Anopheles Species
2) By Vaccine Type: Pre-Erythrocytic; Erythrocytic; Multi-antigen; Other Vaccines
3) By Route Of Administration: Intramuscular; Subcutaneous; Intradermal; Other Routes
4) By Distribution Channel: Public; Private Subsegments:
1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine; Other Experimental Vaccines
2) By Plasmodium Vivax: Candidate Vaccines In Development; Combination Vaccines
3) By Anopheles Species: Transmission-Blocking Vaccines; Vector Control Approaches For further insights on this market, request a sample here

North America was the largest region in the malaria vaccines market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the malaria vaccines market report are Pfizer Inc., Ipca Laboratories Ltd., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., Takeda Pharmaceutical Co Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Lupin, Taj Pharmaceuticals Limited., Nobelpharma Co. Ltd., Bliss GVS Pharma Ltd., Sanaria Inc., Precigen Inc., AdvaCare Pharma, CellFree Sciences, Actiza Pharmaceutical Private Limited, Sumaya Biotech, VLP Therapeutics LLC, GeoVax Labs Inc., Zydus Cadila, Genvec Inc.. For further insights on this market, request a sample here.

Major trends in this market include Innovations And Strategies To Combat Mosquito-Borne Diseases. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Malaria Vaccines Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon